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Abstract
Purpose This study evaluated differences in stress response
and immunological function following laparoscopic and
conventional total mesorectal excision (TME) for rectal
cancer.
Methods Patients with non-metastasized rectal cancer were
prospectively randomized to open (n=18) or laparoscopic
(n=22) TME. Blood samples were taken preoperatively
(baseline), 2, 24, and 72 h following surgery. Systemic
white blood cell and monocyte count, C-reactive protein,
interleukin-6 (IL-6), interleukin-8 (IL-8), HLA-DR expres-
sion on monocytes, growth hormone, prolactin, and cortisol
were measured.
Results Forty patients with a median age of 66 years
(interquartile range, 60–74 years) were included. Eighteen
patients (45%) were randomized to open surgery and 22
patients (55%) to laparoscopic surgery. Patient demograph-
ics in terms of gender, age, BMI, ASA classification,
localization of the tumor, and type of neoadjuvant therapy
were comparable for both groups. Laparoscopic surgery
resulted in a significantly better short-term preservation of
postoperative immune function. HLA-DR expression on
monocytes was significantly higher (64% vs 50%, P=
0.014) and IL-6 level increase was significantly lower (4.6
vs 10.8, P=0.003) 2 h after laparoscopic surgery. No
differences between the open and laparoscopic technique
were observed in postoperative white blood cell count,
monocyte count, C-reactive protein, IL-8, growth hormone,
prolactin, and cortisol levels.
Conclusion Short-term postoperative immune and inflam-
matory functions tended to be better after laparoscopic
rectal surgery. However, the differences were not consistent
at all time intervals, making a definitive conclusion
difficult. Better preserved inflammatory function 2 h after
surgery may reflect a reduction in operative trauma when
the laparoscopic technique is compared with open rectal
procedures.
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Introduction
Conventional or laparoscopic surgery is a controlled trauma
with a stress response and immunological consequences.
Operative trauma, measured by the magnitude and type of
intra-operative injury determine the extent and duration of
the postoperative inflammatory and immunological
responses. Postoperative immunesuppression may have
important consequences as it has been related to infectious
complications and tumor metastasis formation [1–3].
Major surgery remains associated with undesirable
postoperative side effects such as pain, cardiopulmonary,
infective and thromboembolic complications, gastrointesti-
nal paralysis, fatigue, and prolonged convalescence. A key
factor in postoperative morbidity is the surgical stress
response with subsequent increased demand on the patient's
reserves and immune competence. Increased demands in
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induced endocrine and metabolic changes. Some laparo-
scopic interventions have been shown to reduce postoper-
ative morbidity [4–9]. Since the introduction of the
laparoscopic approach, immunological competence and
stress response to surgery have been increasingly studied
in an attempt to explain short-term advantages found for
some minimally invasive techniques [10–14]. The most
studied cytokine is interleukin-6 (IL-6). It reflects the
operative trauma and is a predictor of postoperative
complications. Laparoscopic interventions such as Nissen
fundoplication [11] and cholecystectomy [14] offer clear
clinical advantages in comparison with the conventional
approach, probably based on a better preserved immune
system. More extensive interventions such as laparoscopic
colectomy have also been shown to provide clinical
benefits such as a reduction of morbidity, less postoperative
pain, earlier recovery, and shorter hospital stay when
compared with the open approach [4–8]. As a result,
laparoscopic colectomy is increasingly becoming the
preferred procedure in clinical practice. At the same time,
laparoscopic total mesorectal excision (TME) in rectal
cancer is being used more frequently, mostly on trial bases.
Currently, no data is available regarding surgical stress
response and immune competence following open or
laparoscopic TME surgery in rectal cancer. As a sub-study
of the randomized COLOR II study, which compares the
open and laparoscopic approach for rectal cancer, we
studied the postoperative stress response, inflammatory
and immune function in patients undergoing open or
laparoscopic TME in an attempt to provide insight into
the differences of postoperative trauma here considered.
Study design
In June 2006, the VU University Medical Center (VUmc)
initiated participation in the COLOR II trial; a randomized
study comparing laparoscopic to open TME in patients with
non-metastasized rectal cancer. All patients who were
randomized until December 2008 for the COLOR II trial
at the VUmc were included into this sub-study.
The primary endpoints of the study were to demonstrate
differences in inflammatory response by evaluating pro-
inflammatory cytokines (interleukin-6 and interleukin-8)
and C-reactive protein (CRP); immune status by evaluating
white blood cells and HLA-DR expression on monocytes;
and stress response by evaluating cortisol, prolactin, and
growth hormone in both groups of patients. The protocol
was approved by the local ethics committee and informed
consent was obtained from all participating patients.
Inclusion and exclusion criteria for the present study were
as described in the COLOR II protocol (www.color2.org)
In the present study, patients were analyzed according to
an intention to treat principle.
Material and methods
Peripheral blood and serum (BD Vacutainer Systems,
Plymouth, UK) were collected preoperatively (baseline),
2, 24, and, 72 h after surgery.
Serum interleukin-6 and interleukin-8 samples were
obtained by centrifugation for 10 min at 3,000 rpm at
4°C. All samples were stored in aliquots at −80°C until
tested.
Inflammatory response
Interleukin-6 and interleukin-8
IL-6 and IL-8 concentrations in serum were measured using
commercially available enzyme-linked immunosorbent as-
say kits (Pelikine compact human ELISA kits, Sanquin,
Amsterdam, the Netherlands).
C-reactive protein
Plasma CRP levels were measured by immunoturbidimetric
method, using the BM/Hitachi 705 (Boeingher, Mannheim,
Germany).
Immune status
White blood cell count and HLA-DR expression
on monocytes
Numbers and phenotype of white blood cells and mono-
cytes were determined in fresh (<2 h) heparinized venous
blood. Phenotyping was performed by using CD14-PE and
HLA-DR-FITC moAbs (Becton Dickinson), subsequent
lysis of erythrocytes, and fixation with paraformaldyde.
Monocyte HLA-DR expression was evaluated by FACS
analysis (FACS Calibur, Becton Dickinson, San Jose, CA,
USA) quantified by using calibration beads (QuantumTM
26, Flow Cytometry Standards Corp, Bangs Laboratories,
Inc, Fishers, IN) and expressed as ratio of the mean
fluorescence intensity post/pre surgery.
Stress response
Cortisol
Cortisol concentrations in serum were measured by com-
petitive immunoassay (Bayer Diagnostics, Mijdrecht, The
Netherlands)
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Prolactin concentrations in serum were measured by
immunometric assay (DPC, Los Angeles, USA)
Growth hormone
Growth hormone concentrations in serum were measured
by immunometric Assay (Bayer Diagnostics, Mijdrecht,
The Netherlands)
Statistical analysis
Statistical analysis was performed using the SPSS software
package (SPSS 16.0 for Windows; SPSS, Chicago, IL,
USA). Medians, means, ranges, and interquartile ranges
were calculated and subsequently depicted when appropri-
ate. The Mann–Whitney U test, Chi-squared test, or Fisher's
exact test were applied when appropriate for group
comparisons. The independent samples T test was used to
compare group means. Significance was set at p<0.05
Results
Forty patients with a median age of 66 years (interquartile
range, 60–74 years) were included in this prospective
randomized trial. Twenty-eight men (70%) and 12 women
(30%) with a median body mass index of 25 kg/m
2
(interquartile range: 23.5–26.4 kg/m
2). Median distance of
the tumor to the anal verge was 10 cm (interquartile range:
5.5–15 cm). Eighteen patients (45%) were randomized to
open surgery and 22 patients (55%) to laparoscopic surgery.
The demographic data are shown in Table 1. Patient
characteristics in terms of gender, age, body mass index,
ASA classification, localization of the tumor, and type of
neoadjuvant therapy were comparable for the open and
laparoscopic groups (Table 1). Furthermore, type of
operation, proximal mesorectal excision, TME, or abdom-
inoperineal resection was comparable. Operation time was
significantly longer for laparoscopic procedures, but was
accompanied by less blood loss. In patients randomized to
laparoscopic surgery, two patients needed some form of
conversion by a Pfannenstiel incision and were analyzed
according to an intention to treat principle.
Morbidity and mortality data, for both groups, are
depicted in Table 2. In the laparoscopic and in the open
group, six (27%) and four (22%) patients had some form of
(infectious) complications (P=0.71), respectively. The
median time to develop the complication in the laparoscop-
ic and open group was 5 days (range 1–10 days) and 6 days
(range 3–7 days), respectively. No mortality was seen in the
laparoscopic group, one patient died 3 days postoperatively
in the open group due to myocardial infarction (P=0.45).
No differences were observed in terms of tumor stage or
extensity of resection (expressed by lymph node harvest
and specimen length).
Inflammatory response
Interleukin-6 levels were comparable for both groups at
baseline (P=0.201). Levels showed a significantly lower
increase 2 h following laparoscopic surgery when compared
to the open approach (4.6 vs. 10.8, P=0.003). No differ-
ences were detected 24 and 72 h following surgery (Fig. 1).
No significant differences between the laparoscopic or open
approach in the increase of C-reactive protein level and IL-
8 levels were detected. (Table 3)
Immune status
Monocyte HLA-DR expression was used as a parameter for
surgery-induced immune competence. HLA-DR expression
was comparable at baseline (P=0.251). Two hours follow-
ing open surgery, an HLA-DR expression on monocytes
was significantly better preserved in the laparoscopic
approach (64% vs. 50%, P=0.014). After 24 and 72 h,
the values did not show any significant difference between
both groups (Fig. 2). No significant differences between the
laparoscopic or open approach in postoperative white blood
cell or monocyte count were detected. (Table 3)
Stress response
Growth hormone, cortisol, and prolactin levels were used to
indicate the postoperative stress response. No significant
differences between both groups were found in postopera-
tive stress response levels. (Table 3)
Discussion
In general, laparoscopic surgery is thought to reduce the
magnitude of operative trauma. If alterations of immune
function and stress response are proportional to the extent
of injury, the response following laparoscopic surgery will
be reduced when compared with conventional surgery.
Many studies have shown that relatively wound-limited
interventions such as laparoscopic Nissen fundoplication
[11] and cholecystectomy [14] are associated with a
tempered systemic inflammatory response and preservation
of the postoperative immune function when compared to
the open approach. The stress response to injury and
surgery has also been previously described. Anterior
pituitary hormone secretion is stimulated by hypothalamic
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Variable Laparoscoopic TME (n=22) Open TME (n=18) Significance
Gender; no. (%) P=0.68
Male 16 (73%) 12 (67%)
Female 6 (27%) 6 (33%)
Age (years); median (interquartile range) 64 (59–74) 67 (61–74) P=0.74
Body mass index (kg/m
2); median, (interquartile range) 24 (23–26) 25 (24–26) P=0.012
ASA classification
1 7 (32%) 5 (28%)
2 10 (45%) 10 (56%)
3 5 (23%) 3 (16%)
Tumor localization
Median distance from anal verge; cm (full range) 11 (6–15) 9 (5–12) P=0.26
Neoadjuvant therapy; no. (%) P=0.69
5 Fractions of 5 Gy 8 (36%) 7 (39%)
28 Fractions of 1.8 Gy 2 (9%) 3 (17%)
Operation
Anterior resection 18 (82%) 13 (7%) P=0.71
Abdominoperineal resection 4 (18%) 5 (28%)
Proximal mesorecatal excision (PME) 11 (61%) 9 (69%) P=0.87
Total mesorectal excision (TME) 7 (39%) 4 (44%)
Operation time (min); median (range) 206 (135–305) 159 (100–205) P=0.001
Blood loss (ml); median (range) 127 (20–350) 328 (100–800) P<0.001
Table 2 Postoperative data and complication within 30 days
Variable Laparoscoopic TME (n=22) Open TME (n=18) Significance
Hospital stay; median (interquartile range) 9 days (5–15) 8 days (7–10) P=0.19
Mortality – 1 (6%) P=0.45
Complications per patient; no. (%) 6(27%) 4 (22%) P=0.71
Anastomosis leak 3 (16%) 1 (9%)
Pelvic abscess 1 (5%) –
Pneumonia – 2 (11%)
Cardiac complaints ––
Ileus 1 (5%) –
Wound infection 1 (5%) 1 (6%)
Tumor stage P=0.17
Astler-Coller A 5 2
Astler-Coller B1 6 3
Astler-Coller B2 5 7
Astler-Coller C1 2 1
Astler-Coller C2 3 3
Astler-Coller X 1 2
Lymph node resection; median (range) 10 (3–23) 9 (3–24) P=0.32
Length resection specimen (cm); median range 25 (12–48) 19 (15–46) P=0.62
Astler-Coller X: complete remission after neoadjuvant therapy
56 Int J Colorectal Dis (2011) 26:53–59releasing factors [15, 16]. Cortisol, growth hormone, and
prolactin are secreted in increased amounts from the
pituitary in response to a surgical stimulus. Currently, there
are few data of postoperative immune function and stress
response after more invasive procedure such as laparoscop-
ic colectomy and rectal resections.
In more extensive operations, with more operative
wound surface such as laparoscopic colectomy, differences
with the conventional approach concerning systemic in-
flammatory and immune response are more difficult to
demonstrate and only a relatively low postoperative IL-6
level has been found consistently in the laparoscopic group.
SEM 2.2 / 2.1 2.3 / 1.2 0.6 / 0.5
Fig. 2 Interleukin-6 expression in fold increase compared to
preoperative. (#, P=0.003)
5.3 / 4.1 SEM 3.9 / 4.6 7.3 / 5.6
Fig. 1 HLA-DR on monocytes in percentage compared to preoper-
ative. (#, P=0.014)
Variable Groups 2 h 24 h 72 h
Leucocyte count Lap 1.6 (0.7–2.9) 1.9 (0.9–2.7) 1.5(0.9–2.8)
Open 1.7 (1.0–3.5) 1.8 (0.9–3.6) 1.7 (1.0–3.2)
Monocyte count Lap 0.8 (0.4–1.1) 1.0 (0.6–1.6) 0.9 (0.5–1.9)
Open 0.8 (0.5–1.2) 0.9 (0.5–1.6) 1.0 (0.4–1.5)
C-reactive protein Lap 7.3 (0.6–45) 36 (1.5–78) 56 (9.6–144)
Open 4.0 (0.7–55) 39 (1.8–65) 47 (14–105)
HLA-DR Lap 0.64 (0.31–1.06)
a 0.41 (0.12–0.73) 0.53 (0.15–1.39)
Open 0.50 (0.32–0.94)
a 0.41 (0.22–0.84) 0.54 (0.21–1.17)
IL-6 Lap 4.6 (0.3–35.8)
a 5.2 (0.3–17.6) 1.8 (0.4–7.5)
Open 10.8 (0.2–27.0)
a 9.7 (1.6–38.9) 2.8 (0.3–8.9)
IL-8 Lap 2.0 (0.4–7.1) 1.7 (0.5–8.1) 1.6 (0.4–7.4)
Open 2.4 (0.8–6.1) 1.3 (0.2–2.6) 1.6 (0.4–6.1)
Growth hormone Lap 2.6 (0.03–1.5) 7.6 (0.03–6.6) 2.9 (0.02–1.6)
Open 9.4 (0.01–3.6) 6.7 (0.05–2.8) 3.9 (0.02–1.3)
Prolactin Lap 3.0 (0.13–12) 0.7 (0.04–2) 0.7 (0.04–1.9)
Open 5.6 (0.3–11) 1.2 (0.13–7.1) 1.1 (0.9–3.1)
Cortisol Lap 1.2 (0.2–2.2) 1.3 (0.2–3.8) 1.3 (0.6–3.8)
Open 1.3 (0.1–3.4) 1.2 (0.4–2.7) 1.9 (0.3–12)
Table 3 Postoperative immune
and stress response
Values are depicted as fold-
increase values with the preop-
erative value set at 100%
aSignificant difference
Int J Colorectal Dis (2011) 26:53–59 57Harmon et al. [17] were the first to describe differences in
postoperative IL-6 levels when laparoscopic colectomy was
compared to the open technique. Wu et al. [10]m e a s u r e d
cytokine levels both in serum as well as in peritoneal drain
fluid. They found significantly lower levels of IL-6 after
laparoscopic surgery confirming the earlier studies. CRP is
the only acute phase protein which was measured. Since IL-
6 is the mean stimulator of CRP production, it is not
surprising that the results are comparable. A large random-
ized study by Schwenk et al. [13] showed significantly lower
peak concentrations of IL-6 and CRP 2 days after colon
surgery. Nevertheless, short-term clinical advantages of
laparoscopic colectomy have been shown in different
randomized studies. This has been the reason to extend the
laparoscopic approach to the surgical treatment of rectal
cancer by means of laparoscopic TME, mostly on trial bases.
To demonstrate clinical differences between open and
laparoscopic TME, especially the rate of local recurrence
and morbidity, the COLOR II study was started. Along with
these questions, the study of biological consequences will
offer more insight in the possible advantages of these two
different surgical approaches to rectal cancer.
In the here presented sub-study of the randomized
COLOR II trial, the immune competence and stress
response following laparoscopic and open TME has
demonstrated some subtle differences between both groups.
Significantly lower levels of IL-6 were detected 2 h
following laparoscopic surgery; in the subsequent days this
difference diminished in concordance with a previous study
presented by our institution regarding open and laparo-
scopic colectomy [10]. Moreover, a significant lower
depression was found in immune competence 2 h following
laparoscopic surgery, since HLA-DR expression was better
preserved. This may be interpreted as an important short-
term enhanced defense mechanism after laparoscopy,
against infections but also theoretically against spreading
malignant cells in the circulation [2]. Wind et al. [18]
described an important increase in circulating tumor cells
shortly after initiating surgery. Therefore, a better preserved
immune function could prevent tumor nestling and there-
fore distant metastases formation. Therefore, it will be
interesting to further investigate if the short-term advan-
tages described in the present study will have oncological
advantages in the long-term. However, in the subsequent
days the differences diminished, as described for the IL-6
levels. No significant differences between open and
laparoscopic surgery were found regarding white blood cell
count, monocyte count, C-reactive protein level,
interleukin-8 level, or cortisol level. Moreover, no differ-
ences could be found regarding postoperative stress
response.
In conclusion, although after both laparoscopic and open
TME a decrease in immune competence is seen, this
competenceisbetterpreservedimmediatelyafterlaparoscopic
surgery when compared to the open approach. Also, IL-6
levelsare lower2hfollowinglaparoscopicsurgery,indicating
a diminished surgical trauma. However, the differences were
not consistent at all time intervals, making a definitive
conclusion difficult. Although, in the present study, the
described differences did not result in any clinical advantages
such as less morbidity, the differences on the short term may
reflect the less-invasive character of the laparoscopic TME
procedure when compared to the open approach. Moreover,
an increased immune response may be mostimportant shortly
after initiating surgery as the level of circulating tumor cells is
highest following manipulation of the tumor [18]. Larger
studies are required for more definitive results.
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